Winning Payer Support for Rapid NGS Biomarker Testing in Oncology
Biomarker testing is a cornerstone of modern oncology, transforming how clinicians diagnose, stratify, and treat cancer. By identifying particular genetic, molecular, or protein characteristics in a patient’s tumor or blood sample, biomarker tests provide invaluable insights into disease behavior and a patient’s potential response to various therapies. In recent years, advances in next-generation sequencing (NGS) […]
Finding Hidden Patient Populations With Unstructured Data
This article was originally published on Norstella’s website. As real-world data (RWD) evolves, the rise of unstructured data—from clinical notes to lab reports—is transforming how life sciences teams identify, understand, and engage with patients and providers. These data sources offer rich, contextual insights into patient experiences, disease progression, and physician decision-making that traditional structured datasets often miss. At […]
Drive HCP Engagement with Smarter Omnichannel Marketing
Pharma companies have made significant strides in omnichannel marketing, building programs that engage healthcare professionals (HCPs) across email, digital, social, and peer-to-peer platforms. However, many of these campaigns are often based on static HCP lists and pre-scheduled sequencing, leaving brand teams unable to adapt to clinical events as they occur. Real-world data (RWD) changes that […]
Starting with the End in Mind: How Pharma Can Build a Smarter Path to Commercialization
This article was originally published in Drug Channels. To chart a clear path to commercialization, a manufacturer must begin with the end in mind. Early market research helps pharma companies understand which clinical endpoints and differentiators an asset will need to succeed at launch. Today, one-third of pharma companies start market access planning in Phase I, and […]
Promoting Your Brand: Six Steps for Success
Months and months of market access planning occur long before a new therapy is approved. Once that therapy is finally on the market, pharma companies must then turn their attention to the art of effective brand promotion. While the first step is identifying the right prescribing physicians, how manufacturers engage with these HCPs is equally […]
Meet Your Launch Goals with Payer and HCP Insights
The weeks preceding a pharma product’s launch date are a critical window for market access teams. The ability to pivot and adjust to last-minute shifts can make all the difference between a successful first year and a disappointing launch trajectory. While much of your market access research may have already been completed by the time […]
Acing Market Access: Six Steps to Take Before Launch
Our first post in this series discussed how early market access research, conducted in the 12-18 months before launch, helps pharma companies identify differentiators and establish accurate expectations. As your organization moves closer to launch, your market access team will need to establish a commercially focused definition for your patient population. You’ll need to identify […]
Digital Best Practices for Communicating Drug Coverage to HCPs
Before physicians prescribe a new therapy, they need to trust that it is the most effective and appropriate treatment for an individual patient. They need education on the drug’s efficacy and safety, dosing and administration, and the clinical criteria that define eligibility. They also need to know if the drug is affordable and accessible for […]
Why Pharma Should Invest in Evidence-Based Physician Education
This article was originally published in BioPharma Dive. For years, many manufacturers have assumed that pre-market physician education was not strictly necessary unless their brand was the first to market or had a novel mechanism of action. With the advent of precision medicine, however, ongoing disease state education has become increasingly critical. Today’s molecular-targeted therapies […]
Measuring Message Efficacy: How to Change HCP Brand Perceptions
Pharma companies share product messaging with providers in a myriad of ways, from email campaigns to social media to next-best-action marketing, print and online media, and industry conferences. Despite the rise of omni-channel marketing, in-person meetings are still a crucial means of communicating a brand’s value, efficacy, and competitive differentiators to healthcare professionals (HCPs). Of […]